Trial Studied treatment Control Patients Size Study type Results NCT

Diabetes type 2 - glucose lowering for cardiovascular prevention in all type of patients

VERTIS CV ongoing ertugliflozinplacebo8000 NCT01986881



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons